The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists
β Scribed by Sayuri N. Friedland; Aaron Leong; Kristian B. Filion; Jacques Genest; Iliana C. Lega; Salvatore Mottillo; Paul Poirier; Jennifer Reoch; Mark J. Eisenberg
- Book ID
- 116213247
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 317 KB
- Volume
- 125
- Category
- Article
- ISSN
- 1555-7162
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The peroxisome proliferator-activated receptors are a family of three ligand-activated transcription factors. Fibrate antihyperlipidemic drugs and thiazolidinedione antihyperglycemic drugs were recently identified as synthetic ligands for these receptors. In addition, certain unsaturated fatty acids
## Abstract Peroxisome proliferatorβactivated receptorβΞ³ (PPARβΞ³) plays a critical role in glucose and lipid metabolism. More recently, PPARβΞ³ ligands have been reported to inhibit the expression of proinflammatory molecules by monocytes/macrophages. Of relevance to CNS disease is that PPARβΞ³ agoni